Observing EEG changes during propofol anesthesia induction
Assessment of EEG Changes During Induction of Propofol Anesthesia Using Wireless Measurement Devices
This study looks at how brain activity changes in healthy patients as they are put under general anesthesia with propofol to see if specific patterns occur.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Oulu Academic / other |
| Locations | 1 site (Lappeenranta) |
| Trial ID | NCT03943745 on ClinicalTrials.gov |
What this trial studies
PropoStatus is a prospective observational study that examines the EEG changes in neurologically healthy patients as they undergo induction of general anesthesia with propofol. The study monitors EEG patterns from the awake state to deep anesthesia, specifically looking for burst suppression patterns. Patients will not receive pre-medication and will provide consent before participating. Vital signs will be monitored, and EEG recordings will be taken using a wireless device during the induction process until the desired depth of anesthesia is achieved.
Who should consider this trial
Good fit: Ideal candidates for this study are neurologically healthy individuals scheduled for elective surgery requiring general anesthesia.
Not a fit: Patients with a BMI over 30 or those with neurological or cardiovascular diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of EEG changes during anesthesia, potentially leading to improved monitoring techniques.
How similar studies have performed: While EEG monitoring during anesthesia is a known practice, this specific observational approach to studying EEG changes with propofol is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA 1-2 (no neurological or cardiovascular diseases) Exclusion Criteria * BMI \> 30
Where this trial is running
Lappeenranta
- South Karelia Central Hospital — Lappeenranta, Finland (Recruiting)
Study contacts
- Principal investigator: Jukka Kortelainen, MD, PhD — University of Oulu
- Study coordinator: Jukka Kortelainen, MD, PhD
- Email: jukka.kortelainen@oulu.fi
- Phone: +358 50 4474909
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.